Acadian Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-718
Closed -$34K 1612
2024
Q3
$34K Buy
+718
New +$34K ﹤0.01% 1899
2023
Q1
Sell
-23,870
Closed -$668K 1726
2022
Q4
$668K Sell
23,870
-83,303
-78% -$2.33M ﹤0.01% 960
2022
Q3
$3.01M Sell
107,173
-21,561
-17% -$605K 0.02% 526
2022
Q2
$4.48M Buy
128,734
+18,586
+17% +$646K 0.02% 435
2022
Q1
$3.95M Buy
110,148
+87,113
+378% +$3.12M 0.02% 513
2021
Q4
$534K Buy
23,035
+4,533
+25% +$105K ﹤0.01% 990
2021
Q3
$350K Sell
18,502
-80,933
-81% -$1.53M ﹤0.01% 1149
2021
Q2
$2M Buy
99,435
+86,816
+688% +$1.75M 0.01% 708
2021
Q1
$231K Buy
12,619
+7,065
+127% +$129K ﹤0.01% 1448
2020
Q4
$112K Sell
5,554
-12,118
-69% -$244K ﹤0.01% 1713
2020
Q3
$331K Sell
17,672
-10,963
-38% -$205K ﹤0.01% 1269
2020
Q2
$642K Buy
+28,635
New +$642K ﹤0.01% 1113
2020
Q1
Sell
-5,076
Closed -$98K 1777
2019
Q4
$98K Sell
5,076
-34,637
-87% -$669K ﹤0.01% 1467
2019
Q3
$788K Buy
39,713
+35,513
+846% +$705K ﹤0.01% 963
2019
Q2
$88K Buy
+4,200
New +$88K ﹤0.01% 1387
2019
Q1
Sell
-3,202
Closed -$63K 1946
2018
Q4
$63K Buy
+3,202
New +$63K ﹤0.01% 1377
2018
Q3
Sell
-19,841
Closed -$302K 1653
2018
Q2
$302K Sell
19,841
-148,243
-88% -$2.26M ﹤0.01% 981
2018
Q1
$3.15M Sell
168,084
-3,178
-2% -$59.6K 0.01% 498
2017
Q4
$3.3M Sell
171,262
-23,535
-12% -$453K 0.01% 452
2017
Q3
$3.48M Sell
194,797
-134,010
-41% -$2.39M 0.02% 426
2017
Q2
$5.87M Sell
328,807
-242,007
-42% -$4.32M 0.03% 365
2017
Q1
$8.28M Sell
570,814
-931,337
-62% -$13.5M 0.04% 325
2016
Q4
$27.7M Sell
1,502,151
-71,835
-5% -$1.32M 0.13% 157
2016
Q3
$29.9M Buy
1,573,986
+755,366
+92% +$14.3M 0.15% 148
2016
Q2
$13.2M Buy
818,620
+366,249
+81% +$5.9M 0.07% 228
2016
Q1
$5.43M Buy
452,371
+136,816
+43% +$1.64M 0.03% 387
2015
Q4
$4.49M Buy
315,555
+286,402
+982% +$4.08M 0.02% 416
2015
Q3
$340K Buy
+29,153
New +$340K ﹤0.01% 824